Try our mobile app

Published: 2025-04-24 00:00:00 ET
<<<  go to LOAN company page
false --12-31 Q1 0001080340 0001080340 2025-01-01 2025-03-31 0001080340 2025-04-24 0001080340 2025-03-31 0001080340 2024-12-31 0001080340 2024-01-01 2024-03-31 0001080340 us-gaap:CommonStockMember 2024-12-31 0001080340 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001080340 us-gaap:TreasuryStockCommonMember 2024-12-31 0001080340 us-gaap:RetainedEarningsMember 2024-12-31 0001080340 us-gaap:CommonStockMember 2023-12-31 0001080340 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001080340 us-gaap:TreasuryStockCommonMember 2023-12-31 0001080340 us-gaap:RetainedEarningsMember 2023-12-31 0001080340 2023-12-31 0001080340 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001080340 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001080340 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0001080340 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001080340 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001080340 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001080340 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0001080340 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001080340 us-gaap:CommonStockMember 2025-03-31 0001080340 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001080340 us-gaap:TreasuryStockCommonMember 2025-03-31 0001080340 us-gaap:RetainedEarningsMember 2025-03-31 0001080340 us-gaap:CommonStockMember 2024-03-31 0001080340 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001080340 us-gaap:TreasuryStockCommonMember 2024-03-31 0001080340 us-gaap:RetainedEarningsMember 2024-03-31 0001080340 2024-03-31 0001080340 2024-01-01 2024-12-31 0001080340 us-gaap:ConstructionLoansMember 2025-03-31 0001080340 LOAN:OriginallyDueInTwoThousandAndSixteenMember 2025-03-31 0001080340 LOAN:OriginallyDueInTwoThousandAndTwentyMember 2025-03-31 0001080340 LOAN:OriginallyDueInTwoThousandAndTwentyTwoMember 2025-03-31 0001080340 LOAN:OriginallyDueInTwoThousandAndTwentyThreeMember 2025-03-31 0001080340 LOAN:OriginallyDueInTwoThousandAndTwentyFourMember 2025-03-31 0001080340 LOAN:OriginallyDueInFirstQuarterTwoThousandTwentyFiveMember 2025-03-31 0001080340 us-gaap:SubsequentEventMember 2025-04-01 2025-04-24 0001080340 LOAN:DevelopersResidentialMember 2025-03-31 0001080340 LOAN:DevelopersCommercialMember 2025-03-31 0001080340 LOAN:DevelopersMixedUsedMember 2025-03-31 0001080340 LOAN:DevelopersResidentialMember 2024-12-31 0001080340 LOAN:DevelopersCommercialMember 2024-12-31 0001080340 LOAN:DevelopersMixedUsedMember 2024-12-31 0001080340 LOAN:WebsterCreditLineMember 2025-03-31 0001080340 LOAN:WebsterCreditLineMember 2025-01-01 2025-03-31 0001080340 LOAN:WebsterCreditLineMember LOAN:AmendedAndRestatedCreditAgreementMember 2025-03-31 0001080340 LOAN:SeniorSecuredNotesMember LOAN:IndentureMember 2016-04-25 0001080340 LOAN:SeniorSecuredNotesMember LOAN:IndentureMember 2016-04-25 2016-04-25 0001080340 LOAN:SeniorSecuredNotesMember 2016-04-25 0001080340 LOAN:MBCFundingIIMember 2016-04-25 2016-04-25 0001080340 LOAN:MBCFundingIIMember 2016-04-25 0001080340 LOAN:MBCFundingIIMember LOAN:ChangeOfControlMember 2016-04-25 2016-04-25 0001080340 LOAN:MrRanMember 2025-03-31 0001080340 LOAN:MrKaoMember 2025-03-31 0001080340 srt:ChiefExecutiveOfficerMember 2011-09-09 2011-09-09 0001080340 srt:MaximumMember us-gaap:CommonStockMember 2023-04-11 2023-04-11 0001080340 us-gaap:CommonStockMember 2023-04-11 2024-04-10 0001080340 LOAN:O2025Q1DividendsMember 2025-02-06 2025-02-06 0001080340 2025-02-06 0001080340 us-gaap:SubsequentEventMember LOAN:O2025Q1DividendsMember 2025-04-17 2025-04-17 0001080340 us-gaap:SubsequentEventMember 2025-04-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares LOAN:Integer xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2025

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______________________________________ to ________________________________

 

Commission File Number: 000-25991

 

MANHATTAN BRIDGE CAPITAL, INC.

(Exact name of registrant as specified in its charter)

 

New York 11-3474831
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer
Identification No.)

 

60 Cutter Mill Road, Great Neck, New York 11021

(Address of principal executive offices)

 

(516) 444-3400

(Registrant’s telephone number, including area code)

 

 

 

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading Symbol(s)

  Name of each exchange on which registered
Common shares, par value $.001   LOAN   Nasdaq Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer   Accelerated filer
  Non-accelerated filer   Smaller reporting company
  Emerging growth company      

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes No

 

As of April 24, 2025, the registrant had a total of 11,438,651 common shares, $.001 par value per share, outstanding.

 

 

 

 

 

 

MANHATTAN BRIDGE CAPITAL, INC.

TABLE OF CONTENTS

 

 

    Page Number
Part I FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements (unaudited)  
 

Consolidated Balance Sheets as of March 31, 2025 and December 31, 2024 (Audited)

3

 

Consolidated Statements of Operations for the Three Month Periods Ended March 31, 2025 and 2024

4

 

Consolidated Statements of Changes in Stockholders’ Equity for the Three Month Periods Ended March 31, 2025 and 2024

5

 

Consolidated Statements of Cash Flows for the Three Month Periods Ended March 31, 2025 and 2024

6

 

Notes to Condensed Consolidated Financial Statements

7
Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

12

Item 3. Quantitative and Qualitative Disclosures about Market Risk 17

Item 4.

Controls and Procedures 17
Part II

OTHER INFORMATION

 
Item 6. Exhibits 18
SIGNATURES 19
EXHIBITS  

 

1

 

 

Forward Looking Statements

 

This report contains forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements are typically identified by the words “believe,” “expect,” “intend,” “estimate” and similar expressions. Those statements appear in a number of places in this report and include statements regarding our intent, belief or current expectations or those of our directors or officers with respect to, among other things, trends affecting our financial condition and results of operations and our business and growth strategies. These forward-looking statements are not guarantees of future performance and involve risks and uncertainties. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors (such factors are referred to herein as “Cautionary Statements”), including but not limited to the following: (i) our loan origination activities, revenues and profits are limited by available funds; (ii) we operate in a highly competitive market and competition may limit our ability to originate loans with favorable interest rates; (iii) our Chief Executive Officer is critical to our business and our future success may depend on our ability to retain him; (iv) if we overestimate the yields on our loans or incorrectly value the collateral securing the loan, we may experience losses; (v) we may be subject to “lender liability” claims; (vi) our due diligence may not uncover all of a borrower’s liabilities or other risks to its business; (vii) borrower concentration could lead to significant losses; (viii) we may choose to make distributions in our own stock, in which case you may be required to pay income taxes in excess of the cash dividends you receive; (ix) an increase in interest rates may impact our profitability; (x) we may be unsuccessful in our efforts to extend or replace the Webster Credit Line (as defined below); and (xi) we may be unsuccessful in our efforts to refinance our 6% senior secured notes, due April 22, 2026 (the “Notes”). The accompanying information contained in this report, including the information set forth under “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” identifies important factors that could cause such differences. Further information on potential factors that could affect our business is described under the heading “Risk Factors” in Part I, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. These forward-looking statements speak only as of the date of this report, and we caution potential investors not to place undue reliance on such statements. We undertake no obligation to update or revise any forward-looking statements. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the Cautionary Statements.

 

All references in this Form 10-Q to “Company,” “we,” “us,” or “our” refer to Manhattan Bridge Capital, Inc. and its wholly-owned subsidiary, MBC Funding II Corp., unless the context otherwise indicates.

 

2

 

 

PART I. FINANCIAL INFORMATION

 

Item 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

MANHATTAN BRIDGE CAPITAL, INC. AND SUBSIDIARY

CONSOLIDATED BALANCE SHEETS

 

       
 

March 31, 2025

(unaudited)

  

December 31, 2024

(audited)

 
Assets        
Loans receivable, net of deferred origination and other fees  $63,672,278   $65,405,731 
Interest and other fees receivable on loans   1,618,826    1,521,033 
Cash
   201,363    178,012 
Cash – restricted   21,769    23,750 
Other assets   119,642    62,080 
Right-of-use asset – operating lease, net   140,836    154,039 
Deferred financing costs, net   12,706    16,171 
Total assets  $65,787,420   $67,360,816 
           
Liabilities and Stockholders’ Equity          
Liabilities:          
Line of credit  $14,825,735   $16,427,874 
Senior secured notes (net of deferred financing costs of $78,214 and $96,985, respectively)   5,921,786    5,903,015 
Accounts payable and accrued expenses   194,801    232,236 
Operating lease liability   153,571    167,119 
Loan holdback   50,000    50,000 
Dividends payable   1,315,445    1,315,445 
Total liabilities   22,461,338    24,095,689 
           
Commitments and contingencies   -     -  
           
Stockholders’ equity:          
Preferred shares - $.01 par value; 5,000,000 shares authorized; none issued and outstanding        
Common shares - $.001 par value; 25,000,000 shares authorized; 11,757,058 issued; 11,438,651 outstanding   11,757    11,757 
Additional paid-in capital   45,565,207    45,561,941 
Less: Treasury stock, at cost – 318,407 shares   (1,070,406)   (1,070,406)
Accumulated deficit   (1,180,476)   (1,238,165)
Total stockholders’ equity   43,326,082    43,265,127 
           
Total liabilities and stockholders’ equity  $65,787,420   $67,360,816 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3

 

 

MANHATTAN BRIDGE CAPITAL, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

 

       
  

Three Months

Ended March 31,

 
   2025   2024 
Revenue:        
Interest income from loans  $1,833,914   $2,142,487 
Origination fees   439,799    430,591 
Total revenue   2,273,713    2,573,078 
           
Operating costs and expenses:          
Interest and amortization of deferred financing costs   451,365    690,589 
Referral fees   144    500 
General and administrative expenses   453,570    410,278 
Total operating costs and expenses   905,079    1,101,367 
           
Income from operations   1,368,634    1,471,711 
Other income   4,500    4,500 
Net income  $1,373,134   $1,476,211 
           
Basic and diluted net income per common share outstanding:          
—Basic  $0.12   $0.13 
—Diluted  $0.12   $0.13 
           
Weighted average number of common shares outstanding:          
—Basic   11,438,651    11,438,673 
—Diluted   11,438,651    11,438,673 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4

 

 

MANHATTAN BRIDGE CAPITAL, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(unaudited)

 

FOR THE THREE MONTHS ENDED MARCH 31, 2025

 

   Shares   Amount   Capital   Shares   Cost   Deficit   Totals 
   Common Shares  

Additional Paid-in

   Treasury Stock   Accumulated    
   Shares   Amount   Capital   Shares   Cost   Deficit    Totals 
Balance, January 1, 2025   11,757,058   $11,757   $45,561,941    318,407   $(1,070,406)  $(1,238,165)  $43,265,127 
Non-cash compensation             3,266                   3,266 
Dividends declared and payable                            (1,315,445)   (1,315,445)
Net income   -    -     -     -     -     1,373,134    1,373,134 
Balance, March 31, 2025   11,757,058   $11,757   $45,565,207    318,407   $(1,070,406)  $(1,180,476)  $43,326,082 

 

FOR THE THREE MONTHS ENDED MARCH 31, 2024

 

   Common Shares  

Additional Paid-in

   Treasury Stock   Accumulated    
   Shares   Amount    Capital   Shares   Cost    Deficit    Totals 
Balance, January 1, 2024   11,757,058   $11,757   $45,548,876    316,407   $(1,060,606)  $(1,567,321)  $42,932,706 
Non-cash compensation             3,266                   3,266 
Purchase of treasury shares                  2,000    (9,800)        (9,800)
Dividends declared and payable                            (1,315,445)   (1,315,445)
Net income   -     -     -     -     -     1,476,211    1,476,211 
Balance, March 31, 2024   11,757,058   $11,757   $45,552,142    318,407   $(1,070,406)  $(1,406,555)  $43,086,938 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

5

 

 

MANHATTAN BRIDGE CAPITAL, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

 

       
  

Three Months

Ended March 31,

 
   2025   2024 
Cash flows from operating activities:          
Net income  $1,373,134   $1,476,211 
Adjustments to reconcile net income to net cash provided by
operating activities -
          
Amortization of deferred financing costs   22,237    21,954 
Adjustment to right-of-use asset - operating lease and liability   (345)   121 
Depreciation   1,390    1,055 
Non-cash compensation expense   3,266    3,266 
Changes in operating assets and liabilities:          
Interest and other fees receivable on loans   (110,915)   (231,202)
Other assets   (58,952)   (35,153)
Accounts payable and accrued expenses   (37,435)   (31,600)
Deferred origination and other fees   (11,437)   (63,996)
Net cash provided by operating activities   1,180,943    1,140,656 
           
Cash flows from investing activities:          
Issuance of short-term loans   (10,940,040)   (9,538,000)
Collections received from loans   12,698,051    10,102,525 
Net cash provided by investing activities   1,758,011    564,525 
           
Cash flows from financing activities:          
Repayment of line of credit, net   (1,602,139)   (1,701,661)
Dividend paid   (1,315,445)   (1,287,073)
Purchase of treasury shares       (9,800)
Net cash used in financing activities   (2,917,584)   (2,998,534)
           
Net increase (decrease) in cash   21,370    (1,293,353)
Cash and restricted cash, beginning of period(1)   201,762    1,691,995 
Cash and restricted cash, end of period(2)  $223,132   $398,642 
           
Supplemental Disclosure of Cash Flow Information:        
Cash paid during the period for interest  $437,993   $667,488 
Cash paid during the period for operating leases  $15,991   $16,370 
           
Supplemental Schedule of Noncash Financing Activities:          
Dividend declared and payable  $1,315,445   $1,315,445 
           
Supplemental Schedule of Noncash Operating and Investing Activities:          
Reduction in interest receivable in connection with the increase in loans receivable  $13,122   $112,271 

 

(1)At December 31, 2024 and 2023, cash and restricted cash included $23,750 and $1,587,773, respectively, of restricted cash.
(2)At March 31, 2025 and 2024, cash and restricted cash included $21,769 and $311,545, respectively, of restricted cash.

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

6

 

 

MANHATTAN BRIDGE CAPITAL, INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2025

 

1. DESCRIPTION OF THE COMPANY

 

The accompanying unaudited condensed consolidated financial statements of Manhattan Bridge Capital, Inc. (“MBC”), a New York corporation founded in 1989, and its consolidated subsidiary, MBC Funding II Corp. (“MBC Funding II”), a New York corporation formed in December 2015 (collectively referred to herein as the “Company”) have been prepared by the Company in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete annual audited financial statements. However, in the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s annual audited consolidated financial statements for the year ended December 31, 2024 and the notes thereto included in the Company’s Annual Report on Form 10-K. Results of consolidated operations for the interim period are not necessarily indicative of the operating results to be attained in the entire fiscal year.

 

The Company offers short-term, secured, non–banking loans to real estate investors (also known as hard money loans) to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

 

Summary of Significant Accounting Policies

 

The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amount of revenues and expenses during the reporting period. Actual amounts could differ from those estimates.

 

The condensed consolidated financial statements include the accounts of MBC and MBC Funding II. All significant intercompany balances and transactions have been eliminated in consolidation.

 

Interest income from commercial loans is recognized, as earned, over the loan period.

 

Loans receivable are presented in the condensed consolidated financial statements at cost, net of deferred origination and other fees, which are amortized over the term of the respective loan.

 

Certain amounts in the consolidated financial statements for March 31, 2024 and December 31, 2024, have been reclassified to align with the presentation for March 31, 2025.

 

2. RECENTLY ISSUED TECHNICAL ACCOUNTING PRONOUNCEMENTS

 

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements.

 

7

 

 

3. CASH – RESTRICTED

 

Restricted cash mainly represents collections received, pending clearance, from the Company’s commercial loans and is primarily dedicated to the reduction of the Webster Credit Line (as defined below), established pursuant to the Amended and Restated Credit Agreement (as defined below, see Note 5).

 

4. COMMERCIAL LOANS

 

Loans Receivable

 

The Company offers short-term secured non–banking loans to real estate investors (also known as hard money loans) to fund their acquisition and construction of properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida. The loans are principally secured by collateral consisting of real estate and accompanied by personal guarantees from the principals of the borrowers. The loans are generally for a term of one year. The short-term loans are initially recorded, and carried thereafter, in the condensed consolidated financial statements at cost, net of deferred origination and other fees, which totaled approximately $557,000 and $569,000 at March 31, 2025 and December 31, 2024, respectively. Most of the loans provide for receipt of interest only during the term of the loan and a balloon payment at the end of the term. At March 31, 2025, the Company was committed to $5,983,256 in construction loans that can be drawn by the borrowers when certain conditions are met.

 

At March 31, 2025, the Company has made loans to four different entities in the aggregate amount of $7,675,000, or 12.0% of its loan portfolio. One individual holds at least a fifty percent interest in each of the different entities. This individual is not affiliated with any officers or directors of the Company.

 

The Company generally grants loans for a term of one year. When a performing loan reaches its maturity and the borrower requests an extension, the Company may extend the term of the loan beyond one year. Prior to granting an extension of any loan, the Company reevaluates the underlying collateral.

 

Credit Risk

 

Credit risk profile based on loan activity as of March 31, 2025 and December 31, 2024:

 

Performing loans 

Developers-

Residential

  

Developers-

Commercial

  

Developers-

Mixed Use

   Total outstanding loans 
March 31, 2025  $54,524,375   $7,380,000   $2,325,000   $64,229,375 
December 31, 2024
(audited)
  $56,149,265   $7,380,000   $2,445,000   $65,974,265 

 

At March 31, 2025, the Company’s loans receivable consisted of loans in the amount of $14,900, $1,370,250, $2,610,000, $12,984,479 and $12,845,000, originally due or committed to lend to borrowers in 2016, 2020, 2022, 2023 and 2024, respectively. The loans receivable also include loans in the amount of $6,433,765 originally due in the first quarter of 2025.

 

Generally, borrowers are paying their interest, and the Company receives a fee in connection with the extension of the loans. In all instances, the borrowers have either signed an extension agreement or are in the process of signing an extension. Accordingly, at March 31, 2025, no loan impairments exist and there are no provisions for impairment credit losses of loans or recoveries thereof.

 

8

 

 

Subsequent to the balance sheet date, approximately $878,000 of the loans receivable at March 31, 2025, were paid down or paid off.

 

5. LINE OF CREDIT

 

The Company executed an Amended and Restated Credit and Security Agreement (as amended, the “Amended and Restated Credit Agreement”), with Webster Business Credit Corporation (“Webster”), Flushing Bank (“Flushing”) and Mizrahi Tefahot Bank Ltd (“Mizrahi” and together with Webster and Flushing, the “Lenders”), which established the Company’s credit line (the “Webster Credit Line”). Currently, the Webster Credit Line provides the Company with a credit line of $32.5 million in the aggregate until February 28, 2026, secured by assignments of mortgages and other collateral. The interest rates relating to the Webster Credit Line equal (i) the Secured Overnight Financing Rate (“SOFR”) plus a premium, which rate aggregated approximately 7.9%, including a 0.5% agency fee, as of March 31, 2025, or (ii) a Base Rate (as defined in the Amended and Restated Credit Agreement) plus 2.00% and a 0.5% agency fee, as chosen by the Company for each drawdown. The Company does not believe there will be any issues in extending the Webster Credit Line or securing a similar line from another bank before its expiration.

 

The Webster Credit Line contains various covenants and restrictions including, among other covenants and restrictions, limiting the amount that the Company can borrow relative to the value of the underlying collateral, maintaining various financial ratios and limitations on the terms of loans the Company makes to its customers, limiting the Company’s ability to pay dividends under certain circumstances, and limiting the Company’s ability to repurchase its common shares, sell assets, engage in mergers or consolidations, grant liens, and enter into transactions with affiliates. In addition, the Webster Credit Line contains a cross-default provision which will deem any default under any indebtedness owed by the Company or its subsidiary, MBC Funding II, as a default under the credit line. Under the Amended and Restated Credit Agreement, the Company may repurchase, redeem or otherwise retire its equity securities in an amount not to exceed ten percent of the Company’s annual net income from the prior fiscal year. Further, the Company may issue up to $20 million in bonds through its subsidiary, of which not more than $10 million of such bonds may be secured by mortgage notes receivable, and provided that the terms and conditions of such bonds are approved by Webster, subject to its reasonable discretion. In addition, Mr. Ran has provided a personal guaranty for the potential amounts owed under the Webster Credit line, with such guaranty not to exceed the sum of $1,000,000 plus any costs relating to the enforcement of the personal guaranty.

 

The Company was in compliance with all covenants of the Webster Credit Line, as amended, as of March 31, 2025. At March 31, 2025, the outstanding amount under the Amended Credit Agreement was $14,825,735. The interest rate on the amount outstanding fluctuates daily. The rate, including a 0.5% agency fee, was approximately 7.9% as of March 31, 2025.

 

6. SENIOR SECURED NOTES

 

On April 25, 2016, in an initial public offering, MBC Funding II issued 6% senior secured notes, due April 22, 2026 (the “Notes”) in the aggregate principal amount of $6,000,000 under the Indenture, dated April 25, 2016, among MBC Funding II, as Issuer, the Company, as Guarantor, and Worldwide Stock Transfer LLC, as Indenture Trustee (the “Indenture”). The Notes, having a principal amount of $1,000 each, are listed on the NYSE American and trade under the symbol “LOAN/26”. Interest accrues on the Notes commencing on May 16, 2016. The accrued interest is payable monthly in cash, in arrears, on the 15th day of each calendar month commencing June 2016.

 

9

 

 

Under the terms of the Indenture, the aggregate outstanding principal balance of the mortgage loans held by MBC Funding II, together with MBC Funding II’s cash on hand, must always equal at least 120% of the aggregate outstanding principal amount of the Notes at all times. To the extent the aggregate principal amount of the mortgage loans owned by MBC Funding II plus MBC Funding II’s cash on hand is less than 120% of the aggregate outstanding principal balance of the Notes, MBC Funding II is required to repay, on a monthly basis, the principal amount of the Notes equal to the amount necessary such that, after giving effect to such repayment, the aggregate principal amount of all mortgage loans owned by MBC Funding II plus, MBC Funding II’s cash on hand at such time is equal to or greater than 120% of the outstanding principal amount of the Notes. For this purpose, each mortgage loan is deemed to have a value equal to its outstanding principal balance, unless the borrower is in default of its obligations.

 

MBC Funding II may redeem the Notes, in whole or in part, at any time after April 22, 2019, upon at least 30 days prior written notice to the Noteholders. The redemption price will be equal to the outstanding principal amount of the Notes redeemed plus the accrued but unpaid interest thereon up to, but not including, the date of redemption, without penalty or premium. No Notes were redeemed by MBC Funding II as of March 31, 2025.

 

MBC Funding II is obligated to offer to redeem the Notes if there occurs a “change of control” with respect to MBC Funding II or the Company or if MBC Funding II or the Company sell any assets unless, in the case of an asset sale, the proceeds are reinvested in the business of the seller. The redemption price in connection with a “change of control” will be 101% of the principal amount of the Notes redeemed plus accrued but unpaid interest thereon up to, but not including, the date of redemption. The redemption price in connection with an asset sale will be the outstanding principal amount of the Notes redeemed plus accrued but unpaid interest thereon up to, but not including, the date of redemption.

 

The Company guaranteed MBC Funding II’s obligations under the Notes, which are secured by its pledge of 100% of the outstanding common shares of MBC Funding II that it owns. The Company plans to refinance the Notes prior to their maturity.

 

The Company’s principal executive officers consist of Assaf Ran, who serves as its Chief Executive Officer and President, and Vanessa Kao, who serves as its Chief Financial Officer. As of March 31, 2025, each of Mr. Ran and Ms. Kao own an aggregate of $704,000 and $288,000 of our Notes, respectively.

 

7. EARNINGS PER COMMON SHARE

 

Basic and diluted earnings per share are calculated in accordance with Accounting Standards Codification (“ASC”) Topic 260, “Earnings Per Share” (“ASC Topic 260”). Under ASC Topic 260, basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of common shares outstanding for the period. The computation of diluted earnings per share is similar to basic earnings per share, except that the denominator is increased to include the potential dilution from the exercise of stock options and warrants for common shares using the treasury stock method. The numerator in calculating both basic and diluted earnings per common share for each period is the reported net income.

 

10

 

 

8. STOCK–BASED COMPENSATION

 

Stock-based compensation expense recognized under ASC Topic 718, “Compensation-Stock Compensation,” for each of the three-month periods ended March 31, 2025 and 2024 of $3,266 represents the amortization of the fair value of 1,000,000 restricted shares granted to the Company’s Chief Executive Officer on September 9, 2011 of $195,968, after adjusting for the effect on the fair value of the stock options related to this transaction. The fair value is being amortized over 15 years. At March 31, 2025, all 1,000,000 shares remained restricted, and the remaining unrecognized stock-based compensation amounted to $18,508. One third of such restricted shares shall vest on each of September 9, 2026, September 9, 2027, and September 9, 2028.

 

9. STOCKHOLDERS’ EQUITY

 

The Company adopted a share buyback program on April 11, 2023, for the repurchase of up to 100,000 of the Company’s common shares. Before this program expired on April 10, 2024, the Company had purchased an aggregate of 56,294 common shares at an aggregate cost of $271,468, including 2,000 common shares repurchased during the first quarter of 2024 at an aggregate cost of $9,800.

 

10. SEGMENT REPORTING

 

The Company reports segment information based on the management approach which designates the internal reporting used by the Chief Operating Decision Maker, which is the Company’s Chief Executive Officer, for making decisions and assessing performance as the source of the Company’s reportable segments. The Company operates as a single reportable segment, originating, servicing, and managing short-term secured commercial loans to real estate investors. Management evaluates performance on a consolidated basis, as all loans share similar risk profiles, underwriting standards, and operational processes. Key performance metrics include interest income, origination fees, loan performance, and operating expenses. Significant expenses reviewed by management include interest and amortization of deferred financing costs and general and administrative expenses, which remain consistent across loan types. There are no material differences between segment-level information and consolidated financial reporting. The Company will continue to evaluate its segment reporting disclosures and make adjustments if there are material changes in business operations or financial reporting requirements.

 

Net income from the Company’s reportable segment is as follows:

 

   2025   2024 
   Three Months Ended March 31, 
   2025   2024 
Lending revenue:  $2,273,713   $2,573,078 
Less:          
Interest expense   429,128    668,635 
Amortization of deferred financing costs   22,237    21,954 
Referral fees   144    500 
General and administrative expenses   453,570    410,278 
Other income   (4,500)   (4,500)
Net income  $1,373,134   $1,476,211 

 

11. COMMITMENT

 

In accordance with the dividend declared by the Company’s Board of Directors on February 6, 2025, a cash dividend of $0.115 per share in an aggregate amount of $1,315,445 was paid on April 15, 2025, to all shareholders of record on April 18, 2025.

 

12. SUBSEQUENT EVENTS

 

On April 17, 2025, the Company’s Board of Directors declared a cash dividend of $0.115 per share to be paid to all shareholders of record on July 8, 2025. The dividend will be paid on July 15, 2025.

 

11

 

 

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and notes thereto included in this Quarterly Report on Form 10-Q. The discussion and analysis contain forward-looking statements based on current expectations that involve risks and uncertainties. Actual results and the timing of certain events may differ significantly from those projected in such forward-looking statements.

 

We are a New York-based real estate finance company that specializes in originating, servicing and managing a portfolio of first mortgage loans. We offer short-term, secured, non-banking loans (sometimes referred to as “hard money” loans), which we may renew or extend on, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

 

The properties securing the loans are generally classified as residential or commercial real estate and, typically, are not income producing. Our loans are generally secured by a first mortgage lien on real estate. In addition, each loan is personally guaranteed by the principal(s) of the borrower, which guarantee may be collaterally secured by a pledge of the guarantor’s interest in the borrower. The face amount of the loans we originated in the past seven years ranged from $40,000 to a maximum of $3.6 million. Our lending policy limits the maximum amount of any loan to the lower of (i) 9.9% of the aggregate amount of our loan portfolio (not including the loan under consideration) and (ii) $4 million. Our loans typically have a maximum initial term of 12 months and bear interest at a fixed rate of 9% to 13% per year, except for one loan issued in June 2024, which had an initial interest rate of 11.5% that was reduced to 7.25% on January 2, 2025, for a period of up to one year. In addition, we usually receive origination fees or “points” ranging from 0% to 2% of the original principal amount of the loan as well as other fees relating to underwriting and funding the loan. Interest is always payable monthly, in arrears. In the case of acquisition financing, the principal amount of the loan usually does not exceed 75% of the value of the property (as determined by an independent appraiser) and in the case of construction financing, it is typically up to 80% of construction costs.

 

Since commencing our business in 2007, except as set forth below, we have never foreclosed on a property, although sometimes we have renewed or extended the term of a loan to enable the borrower to avoid premature sale or refinancing of the property. When we renew or extend a loan, we generally receive additional “points” and other fees. In June 2023, we filed a foreclosure lawsuit relating to one property, as a result of a deed transfer from the borrower to a buyer without our consent. In that instance, the buyer of the property on which we had a valid mortgage suffered a data breach which resulted in the failure of the buyer to remit the funds needed for the loan payoff. In October 2023, we received the entire payoff amount for the loan receivable, including all unpaid fees, to rectify the situation.

 

12

 

 

Our primary business objective is to grow our loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to our shareholders over the long term through dividends. We intend to achieve this objective by continuing to selectively originate, fund loans secured by first mortgages on residential and commercial real estate held for investment located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida, and to carefully manage and service our portfolio in a manner designed to generate attractive risk-adjusted returns across a variety of market conditions and economic cycles. We believe that current market dynamics specifically the demand/supply imbalance for relatively small real estate loans, presents opportunities for us to selectively originate high-quality first mortgage loans and we believe that these market conditions should persist for a number of years. We have built our business on a foundation of intimate knowledge of the New York metropolitan area real estate market combined with a disciplined credit and due diligence culture that is designed to protect and preserve capital. We believe that our flexibility and ability to structure loans that address the needs of our borrowers without compromising our standards on credit risk, our expertise, our intimate knowledge of the New York metropolitan area real estate market and our focus on newly originated first mortgage loans, has defined our success until now and should enable us to continue to achieve our objectives.

 

A principal source of new transactions has been repeat business from prior customers and their referral of new business. We also receive leads for new business from banks, brokers and a limited amount of advertising. Finally, our Chief Executive Officer also spends a significant portion of his time on new business development. We rely on our own employees, independent legal counsel, and other independent professionals to verify titles and ownership, to file liens and to consummate the transactions. Outside appraisers are used to assist us in evaluating the worth of collateral, when deemed necessary by management. We also use construction inspectors.

 

For the three month periods ended March 31, 2025 and 2024, the total amounts of $10,953,162 and $9,650,271, respectively, have been lent, offset by collections received from borrowers under our commercial loans in the amounts of $12,698,051 and $10,102,525, respectively.

 

At March 31, 2025, we were committed to $5,983,256 in construction loans that can be drawn by our borrowers when certain conditions are met.

 

To date, none of the loans previously made have been non-collectable, although no assurances can be given that existing or future loans may not prove to be non-collectible or foreclosed in the future.

 

We satisfied all of the requirements to be taxed as a real estate investment trust (“REIT”) and elected to be taxed as a REIT commencing with our taxable year ended December 31, 2014. In order to maintain our qualification for taxation as a REIT and avoid any excise tax on our net taxable income, we are required to distribute each year at least 90% of our REIT taxable income. If we distribute less than 100% of our taxable income (but more than 90%), the undistributed portion will be taxed at the regular corporate income tax rates. As a REIT, we may also be subject to federal excise taxes and minimum state taxes.

 

13

 

 

Results of Operations

 

Three months ended March 31, 2025 compared to three months ended March 31, 2024

 

Revenue

 

Total revenues for the three months ended March 31, 2025 were approximately $2,274,000, compared to approximately $2,573,000 for the three months ended March 31, 2024, a decrease of $299,000, or 11.6%. The decrease in revenue was primarily attributable to lower interest income, resulting from a reduction in loans receivable, period over period. For the three months ended March 31, 2025, approximately $1,834,000 of our revenue represents interest income on secured commercial loans that we offer to real estate investors, compared to approximately $2,142,000 for the same period in 2024, and approximately $440,000 and $431,000, respectively, represent origination fees on such loans. The loans are principally secured by collateral consisting of real estate and accompanied by personal guarantees from the principals of the borrowers.

 

Interest and amortization of deferred financing costs

 

Interest and amortization of deferred financing costs for the three months ended March 31, 2025 were approximately $451,000, compared to approximately $691,000 for the three months ended March 31, 2024, a decrease of $240,000, or 34.7%. The decrease is primarily attributable to the decrease in interest expense due to lower SOFR rates and a reduction in borrowed amounts related to the use of the Webster Credit Line (see Note 5 to the condensed consolidated financial statements included elsewhere in this quarterly report on Form 10-Q).

 

General and administrative expenses

 

General and administrative expenses for the three months ended March 31, 2025 were approximately $454,000 compared to approximately $410,000 for the three months ended March 31, 2024, an increase of $44,000, or 10.7%. The increase is primarily attributable to increases in payroll and appraisal expenses, partially offset by reductions in travel and meals expenses.

 

Net income

 

Net income for the three months ended March 31, 2025 was approximately $1,373,000 compared to approximately $1,476,000 for the three months ended March 31, 2024, a decrease of $103,000, or 7.0%. This decrease is primarily attributable to the decrease in interest income from loans, partially offset by the decrease in interest expense.

 

Liquidity and Capital Resources

 

At March 31, 2025, we had cash of approximately $201,000, compared to cash of approximately $178,000 at December 31, 2024, not including restricted cash, which mainly represents collections received, pending clearance, from the Company’s commercial loans and is primarily dedicated to the reduction of the Webster Credit Line.

 

For the three months ended March 31, 2025, net cash provided by operating activities was approximately $1,181,000, compared to approximately $1,141,000 for the three months ended March 31, 2024. The increase in net cash provided by operating activities was primarily due to a smaller increase in interest and other fees receivable on loans compared to the prior period, partially offset by the decrease in net income.

 

14

 

 

For the three months ended March 31, 2025, net cash provided by investing activities was approximately $1,758,000, compared to approximately $565,000 for the three months ended March 31, 2024. Net cash provided by investing activities for the three months ended March 31, 2025 consisted of the collection of our commercial loans of approximately $12,698,000, offset by the issuance of commercial loans of approximately $10,940,000. Net cash provided by investing activities for the three months ended March 31, 2024 consisted of the collection of our commercial loans of approximately $10,103,000, offset by the issuance of commercial loans of $9,538,000.

 

For the three months ended March 31, 2025, net cash used in financing activities was approximately $2,918,000, compared to approximately $2,999,000 for the three months ended March 31, 2024. Net cash used in financing activities for the three months ended March 31, 2025 reflects the repayment of the Webster Credit Line of approximately $1,602,000 and a dividend payment of approximately $1,315,000. Net cash used in financing activities for the three months ended March 31, 2024 reflects the repayment of the Webster Credit Line of approximately $1,702,000, a dividend payment of approximately $1,287,000 and the purchase of treasury shares of approximately $10,000.

 

Our Amended and Restated Credit and Security Agreement with Webster, Flushing Bank and Mizrahi provides for the Webster Credit Line. Currently, the Webster Credit Line provides us with a credit line of $32.5 million in the aggregate until February 28, 2026, secured by assignments of mortgages and other collateral. The interest rates relating to the Webster Credit Line equal (i) SOFR plus a premium, which rate aggregated approximately 7.9%, including a 0.5% agency fee, as of March 31, 2025, or (ii) a Base Rate (as defined in the Amended and Restated Credit Agreement) plus 2.00% and a 0.5% agency fee, as chosen by the Company for each drawdown.

 

The Webster Credit Line contains various covenants and restrictions including covenants limiting the amount that the Company can borrow relative to the value of the underlying collateral, maintaining various financial ratios and limitations on the terms of loans the Company makes to its customers, limiting the Company’s ability to pay dividends under certain circumstances, and limiting the Company’s ability to repurchase its common shares, sell assets, engage in mergers or consolidations, grant liens, and enter into transactions with affiliates. In addition, the Webster Credit Line contains a cross default provision which will deem any default under any indebtedness owed by us or our subsidiary, MBC Funding II, as a default under the credit line. Under the Amended and Restated Credit Agreement, the Company may repurchase, redeem or otherwise retire its equity securities in an amount not to exceed ten percent of our annual net income from the prior fiscal year. Further, the Company may issue up to $20 million in bonds through its subsidiary, of which not more than $10 million of such bonds may be secured by mortgage notes receivable, and provided that the terms and conditions of such bonds are approved by Webster, subject to its reasonable discretion. In addition, Mr. Ran has provided a personal guaranty of the potential amounts owed under the Webster Credit Line, with such guaranty not to exceed the sum of $1,000,000 plus any costs relating to the enforcement of the personal guaranty.

 

We were in compliance with all covenants of the Webster Credit Line, as amended, as of March 31, 2025. At March 31, 2025, the outstanding amount under the Amended and Restated Credit Agreement was $14,825,735. The interest rate on the amount outstanding fluctuates daily. The rate, including a 0.5% agency fee, was approximately 7.9% as of March 31, 2025.

 

MBC Funding II has $6,000,000 of outstanding principal amount of Notes. The Notes mature on April 22, 2026, unless redeemed earlier, and accrue interest at a rate of 6% per annum commencing on May 16, 2016 and will be payable monthly, in arrears, in cash, on the 15th day of each calendar month, commencing June 2016.

 

15

 

 

Under the terms of the Indenture, the aggregate outstanding principal balance of the mortgage loans held by MBC Funding II, together with its cash on hand, must always equal at least 120% of the aggregate outstanding principal amount of the Notes at all times. To the extent the aggregate principal amount of the mortgage loans owned by MBC Funding II plus its cash on hand is less than 120% of the aggregate outstanding principal balance of the Notes, MBC Funding II is required to repay, on a monthly basis, the principal amount of the Notes equal to the amount necessary such that, after giving effect to such repayment, the aggregate principal amount of all mortgage loans owned by it plus, its cash on hand at such time is equal to or greater than 120% of the outstanding principal amount of the Notes. For this purpose, each mortgage loan is deemed to have a value equal to its outstanding principal balance, unless the borrower is in default of its obligations.

 

 

The Notes are secured by a first priority lien on all of MBC Funding II’s assets, including, primarily, mortgage notes, mortgages and other transaction documents entered into in connection with first mortgage loans originated and funded by us, which MBC Funding II acquired from MBC pursuant to an asset purchase agreement. MBC Funding II may redeem the Notes, in whole or in part, at any time after April 22, 2019 upon at least 30 days prior written notice to the noteholders. The redemption price will be equal to the outstanding principal amount of the Notes redeemed plus the accrued but unpaid interest thereon up to, but not including, the date of redemption, without penalty or premium. No Notes were redeemed by MBC Funding II as of March 31, 2025.

 

MBC Funding II is obligated to offer to redeem the Notes if there occurs a “change of control” with respect to us or MBC Funding II or if we or MBC Funding II sell any assets unless, in the case of an asset sale, the proceeds are reinvested in the business of the seller. The redemption price in connection with a “change of control” will be 101% of the principal amount of the Notes redeemed plus accrued but unpaid interest thereon up to, but not including, the date of redemption. The redemption price in connection with an asset sale will be the outstanding principal amount of the Notes redeemed plus accrued but unpaid interest thereon up to, but not including, the date of redemption.

 

We guarantee MBC Funding II’s obligations under the Notes, which are secured by our pledge of 100% of the outstanding common shares of MBC Funding II that we own.

 

On April 11, 2023, our board of directors authorized a share buyback program for the repurchase of up to 100,000 of our common shares. Before this program expired on April 10, 2024, we had purchased an aggregate of 56,294 common shares at an aggregate cost of approximately $271,000.

 

We expect that our current cash balances, the Amended and Restated Credit Agreement, as described above, and cash flows from operations will be sufficient to fund our operations over the next 12 months. We currently do not believe there will be any issues in extending the Webster Credit Line or securing a similar line from another bank before its expiration, and we plan to refinance the Notes prior to their maturity, though we cannot assure that we will be successful in doing so on favorable terms or at all. From time to time, we also receive short-term unsecured loans from our executive officers and others, providing us with the flexibility needed for the steady deployment of capital. However, we anticipate that our working capital requirements will increase in the coming 12 months as we continue to pursue growth under favorable conditions.

 

16

 

 

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a smaller reporting company, we are not required to provide the information required by this Item.

 

Item 4. CONTROLS AND PROCEDURES

 

(a)Evaluation and Disclosure Controls and Procedures

 

Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of March 31, 2025 (the “Evaluation Date”). Based upon that evaluation, the chief executive officer and the chief financial officer concluded that, as of the Evaluation Date, our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act (i) are recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms and (ii) are accumulated and communicated to our management, including its chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.

 

(b)Changes in Internal Control Over Financial Reporting

 

There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) or 15d-15(f) under the Exchange Act) during the fiscal quarter ended March 31, 2025 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

17

 

 

PART II OTHER INFORMATION

 

Item 6. EXHIBITS

 

Exhibit No.   Description
     
31.1   Chief Executive Officer Certification under Rule 13a-14
31.2   Chief Financial Officer Certification under Rule 13a-14
32.1*   Chief Executive Officer Certification pursuant to 18 U.S.C. section 1350
32.2*   Chief Financial Officer Certification pursuant to 18 U.S.C. section 1350
101.INS   Inline XBRL Instance Document
101.CAL   Inline XBRL Taxonomy Extension Schema Document
101.SCH   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
104   Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101).

 

 

* Furnished, not filed, in accordance with item 601(32)(ii) of Regulation S-K.

 

18

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

      Manhattan Bridge Capital, Inc. (Registrant)
         
Date: April 24, 2025 By: /s/ Assaf Ran
        Assaf Ran, President and Chief Executive Officer
         (Principal Executive Officer)
         
Date: April 24, 2025  
      By: /s/ Vanessa Kao
        Vanessa Kao, Chief Financial Officer
        (Principal Financial and Accounting Officer)

 

19